Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes

October 2016

Author(s): Anyanwagu U, Mamza J, Mehta R, Donnelly R, Idris I

Heart. 2016;102(19):1581-7.*10.1136/heartjnl-2015-309164

NIHR Acknowledged: Yes

People
Photo Name Bio